黃 曼舒

Medicine & Life Sciences

1. Ependymoma 100%
2. Medulloblastoma 94%
3. 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine 69%
4. Thiosulfates 59%
5. Growth Inhibitors 50%
6. Circulating Neoplastic Cells 47%
7. Taiwan 46%
8. Myasthenia Gravis 44%
9. Thyroid Diseases 43%
10. Child 41%
11. Heterografts 40%
12. Pediatrics 33%
13. Neoplasms 30%
14. B-Lymphocytes 29%
15. Breast Neoplasms 24%
16. Neoplasm Metastasis 23%
17. Therapeutics 23%
18. Recurrence 19%
19. Macrophages 18%
20. Liquid Biopsy 18%
21. Everolimus 16%
22. Pharmaceutical Preparations 15%
23. Thigh 15%
24. Bone and Bones 15%
25. Preclinical Drug Evaluations 15%
26. Oligonucleotide Array Sequence Analysis 13%
27. DNA Methylation 12%
28. entrectinib 12%
29. Hedgehog Proteins 10%
30. Drug Therapy 10%
31. Control Groups 10%
32. Brain Neoplasms 9%
33. Datasets 9%
34. Survival Rate 9%
35. Preexisting Condition Coverage 9%
36. Survival 9%
37. Radiotherapy 8%
38. Whole Body Imaging 8%
39. Mast Cells 8%
40. Salvage Therapy 7%
41. Pleura 7%
42. RNA-Seq 7%
43. Mediastinum 7%
44. Precision Medicine 6%
45. Radiation Exposure 6%
46. Drug Combinations 6%
47. Adjuvant Chemotherapy 6%
48. Catastrophic Illness 6%
49. Computational Biology 6%